🇨🇦 20-valent pneumococcal conjugate vaccine (20vPnC) in Canada

20-valent pneumococcal conjugate vaccine (20vPnC) (20-valent-pneumococcal-conjugate-vaccine-20vpnc) regulatory status in Canada.

Marketing authorisation

20-valent pneumococcal conjugate vaccine (20vPnC) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in Canada

Frequently asked questions

Is 20-valent pneumococcal conjugate vaccine (20vPnC) approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for 20-valent pneumococcal conjugate vaccine (20vPnC) in Canada?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.